U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07143929) titled 'To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL' on Aug. 20.
Brief Summary: To observe the efficacy and safety of CD7-targeted chimeric antigen receptor T cells in the treatment of refractory or relapsed PTCL.
Study Start Date: Aug. 18
Study Type: INTERVENTIONAL
Condition:
CD7 Positive R/R PTCL
Intervention:
DRUG: CAR-T
autologous CD7-targeted CAR-T cells, single injection
Recruitment Status: RECRUITING
Sponsor: Peking University People's Hospital
Disclaimer: Curated by HT Syndication....